These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 25704615

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Differential distribution of SK channel subtypes in the brain of the weakly electric fish Apteronotus leptorhynchus.
    Ellis LD, Maler L, Dunn RJ.
    J Comp Neurol; 2008 Apr 20; 507(6):1964-78. PubMed ID: 18273887
    [Abstract] [Full Text] [Related]

  • 43. SK (KCa2) channels do not control somatic excitability in CA1 pyramidal neurons but can be activated by dendritic excitatory synapses and regulate their impact.
    Gu N, Hu H, Vervaeke K, Storm JF.
    J Neurophysiol; 2008 Nov 20; 100(5):2589-604. PubMed ID: 18684909
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. The relationship between functional inhibition and binding for K(Ca)2 channel blockers.
    Benton DC, Garbarg M, Moss GW.
    PLoS One; 2013 Nov 20; 8(9):e73328. PubMed ID: 24039913
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Determinants of apamin and d-tubocurarine block in SK potassium channels.
    Ishii TM, Maylie J, Adelman JP.
    J Biol Chem; 1997 Sep 12; 272(37):23195-200. PubMed ID: 9287325
    [Abstract] [Full Text] [Related]

  • 49. The SK3 subunit of small conductance Ca2+-activated K+ channels interacts with both SK1 and SK2 subunits in a heterologous expression system.
    Monaghan AS, Benton DC, Bahia PK, Hosseini R, Shah YA, Haylett DG, Moss GW.
    J Biol Chem; 2004 Jan 09; 279(2):1003-9. PubMed ID: 14559917
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Identification of a pharmacophore of SKCa channel blockers.
    Dilly S, Graulich A, Farce A, Seutin V, Liegeois JF, Chavatte P.
    J Enzyme Inhib Med Chem; 2005 Dec 09; 20(6):517-23. PubMed ID: 16408787
    [Abstract] [Full Text] [Related]

  • 54. Tonic PKA Activity Regulates SK Channel Nanoclustering and Somatodendritic Distribution.
    Abiraman K, Sah M, Walikonis RS, Lykotrafitis G, Tzingounis AV.
    J Mol Biol; 2016 Jun 05; 428(11):2521-2537. PubMed ID: 27107637
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Preferred Formation of Heteromeric Channels between Coexpressed SK1 and IKCa Channel Subunits Provides a Unique Pharmacological Profile of Ca2+-Activated Potassium Channels.
    Higham J, Sahu G, Wazen RM, Colarusso P, Gregorie A, Harvey BSJ, Goudswaard L, Varley G, Sheppard DN, Turner RW, Marrion NV.
    Mol Pharmacol; 2019 Jul 05; 96(1):115-126. PubMed ID: 31048549
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Small-conductance calcium-activated potassium (SK) channels in the amygdala mediate pain-inhibiting effects of clinically available riluzole in a rat model of arthritis pain.
    Thompson JM, Ji G, Neugebauer V.
    Mol Pain; 2015 Aug 28; 11():51. PubMed ID: 26311432
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.